May 22, 2018

Did You Purchase Onconova Therapeutics, Inc. (ONTX) through Laidlaw and Company?

Investment Loss

Soreide Law Group has been contacted by clients who purchased Onconova Therapeutics, Inc. (ONTX) and experienced significant stock losses through the sale of the stock brokers at Laidlaw and Company. Laidlaw is listed on their website as the “Sole Book Runner” from the April 2017 offering. Securities that are newly issued are often more volatile than the more established companies, and if you, as the investor, were not looking to speculate, this could have been a highly unsuitable recommendation given to you by your broker from Laidlaw and Company.
According to Yahoo Finance, Onconova Therapeutics, Inc. (ONTX), a clinical-stage biopharmaceutical company, focusing on discovering and developing small molecule product candidates to treat cancer. The company has a license agreement with SymBio Pharmaceuticals Limited; a development and license agreement with Baxter Healthcare SA; a license, development, and commercialization agreement with Pint International SA; and a license and collaboration agreement with HanX Biopharmaceuticals, Inc. Onconova Therapeutics, Inc. was founded in 1998 and is headquartered in Newtown, Pennsylvania.
In April of 2017, Onconova Therapeutics, Inc. (ONTX) was trading around 2.7, and today it is trading at approximately 0.37. The 52-week change is -81.89%%.
On Laidlaw and Company’s website, the following information on their company is given:”Our team of bankers’ focus on the healthcare industry and the depth of their experience allows them to provide comprehensive knowledge of both the industry and the markets.
If you’ve experienced financial losses in Onconova Therapeutics, Inc. (ONTX) due to the recommendations of Laidlaw and Company’s securities brokers, call Soreide Law Group for a no cost consultation with an experienced securities lawyer regarding the possibility of recovering your significant financial losses through a FINRA arbitration at: 888-760-6552.
Soreide Law Group represents our clients nationwide before FINRA.  We operate on a contingency fee basis, no fee if no recovery.

Recent Posts

March 26, 2024
Stifel Fined $400K by FINRA

According to a recent article in Wealth Management, Stifel will pay over $400,000 to settle FINRA disciplinary charges that the firm allegedly did not properly supervise one of their registered representatives who misappropriated over $100,000 from an elderly client. Stifel agreed to the penalties without admitting or denying FINRA’s findings. In addition to a $400,000 penalty, Stifel […]

March 18, 2024
JAYSON R POCIUS Barred by FINRA

JAYSON R POCIUS, a former broker with Wells Fargo Advisors Financial Network, LLC of Arlington Heights, IL, who was registered with Wells Fargo from 2019 through June of 2023, was barred from the securities industry by FINRA on March 8, 2024, after he failed to cooperate with an investigation by the Financial Industry Regulatory Authority […]

March 15, 2024
William Savary Fined, Involved In Investor Complaint

Soreide Law Group is looking into possible investor claims on behalf of those who incurred losses through securities broker William Savary [CRD: 1069141, Gig Harbor, Washington]. Evidently, Savary joined Abraham Securities Corporation on August 12, 2021. He previously worked for Spencer-Winston Securities Corporation from October 3, 2019, to July 23, 2020. Keep reading to learn […]

Contact us Nationwide USA
2401 E. Atlantic Blvd., Suite 305, Pompano Beach, FL 33062
Helping clients recover money across the USA
search
Copyright © 2022 Soreide Law Group, PLLC  |  All Rights Reserved
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram